keyword
https://read.qxmd.com/read/38734574/the-drug-design-development-seminar-2024-combining-efforts-towards-human-and-animal-parasitic-diseases
#1
JOURNAL ARTICLE
Richard J Marhöfer, Sandra Noack, Paul M Selzer
No abstract text is available yet for this article.
May 10, 2024: Trends in Parasitology
https://read.qxmd.com/read/38734572/innovative-cancer-follow-up-with-telehealth-a-new-method-for-oncology-nurses
#2
JOURNAL ARTICLE
Elif Donmez, Bulent Kilic, Zeynep Dulger, Turkan Ozdas
OBJECTIVES: Telenavigation (TN) is an innovative cancer follow-up method for oncology nurses. Little is known about the effectiveness of tele-navigation on cancer patients. This study investigated the opinions of healthcare providers (HCPs) and colorectal cancer patients' experience regarding patient follow-up with TN. DATA SOURCES: This is a phenomenological qualitative study. Semistructured interviews were conducted with fifteen patients and eight healthcare providers...
May 11, 2024: Seminars in Oncology Nursing
https://read.qxmd.com/read/38734522/online-training-or-face-to-face-training-from-the-perspective-of-ear-nose-and-throat%C3%A2-and-head-and-neck-surgeons
#3
JOURNAL ARTICLE
Elif Kaya Çelik, Sümeyra Doluoğlu, Hatice Güzelküçük Akay, Emel Çadalli Tatar, Mehmet Hakan Korkmaz
PURPOSE: To determine the preferences of Ear, Nose, and Throat (ENT) and Head-Neck Surgery (HNS) specialists and residents undergoing training for online or face-to-face training and the factors affecting the preference. METHODS: An 16-item questionnaire was created using Google Forms and was administered to residents undergoing training in ENT departments and to specialists working in the same field. The questionnaires were distributed online and requested to be completed between August and October 2020...
May 10, 2024: Journal of Voice
https://read.qxmd.com/read/38734484/the-differential-diagnosis-of-lymphoepithelial-lesion-of-the-salivary-gland
#4
REVIEW
Makoto Urano, Masato Nakaguro
The differential diagnosis of salivary gland lesions with epithelial components and lymphoid stroma is often challenging. Salivary gland carcinoma with tumor-associated lymphoid proliferation, tumors composed of both epithelial and lymphoid components, lymphoid neoplasms in the salivary gland, and inflammatory lesions are all included in this category. It encompasses inflammatory lesions and neoplastic lesions. With the exception of Warthin tumors, these lesions are rare, making them more difficult to diagnose...
May 1, 2024: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/38733984/optimizing-venous-stenting-consensus-recommendations-for-enhanced-management-of-lower-extremity-deep-vein-thrombosis
#5
JOURNAL ARTICLE
Javier Trujillo-Santos, Pablo Demelo-Rodríguez, Alexis Bravo de Laguna-Taboada, Santiago Zubicoa-Ezpeleta, Alejandro Rodríguez-Morata, Ignacio Lojo-Rocamonde, Antoni Riera-Mestre
INTRODUCTION:  Deep vein thrombosis (DVT) poses a complex challenge and often leads to postthrombotic syndrome (PTS), a debilitating complication. The emergence of venous stents offers a potential preventive avenue against this complication. This study aimed to provide consensus recommendations on the use of venous stent for DVT. MATERIALS AND METHODS:  From June to July 2023, 20 internal medicine, angiology and vascular surgery, and vascular and interventional radiology experts were involved in the Delphi process...
May 11, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38733983/thrombophilia-screening-not-so-straightforward
#6
JOURNAL ARTICLE
Gary W Moore
Although inherited thrombophilias are lifelong risk factors for a first thrombotic episode, progression to thrombosis is multifactorial and not all individuals with inherited thrombophilia develop thrombosis in their lifetimes. Consequently, indiscriminate screening in patients with idiopathic thrombosis is not recommended, since presence of a thrombophilia does not necessarily predict recurrence or influence management, and testing should be selective. It follows that a decision to undertake laboratory detection of thrombophilia should be aligned with a concerted effort to identify any significant abnormalities, because it will inform patient management...
May 11, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38733982/nonsevere-hemophilia-the-need-for-a-renewed-focus-and-improved-outcomes
#7
JOURNAL ARTICLE
Gerard Dolan, Karin Fijnvandraat, Peter J Lenting, Cristina Catarino, Michelle Lavin
People with nonsevere hemophilia (PWNSH) are phenotypically more diverse than those with severe hemophilia. Perceptions relating to a "nonsevere" phenotype have contributed to fewer research initiatives, fewer guidelines on optimal management, and a lack of standards for surveillance and clinical assessment for affected individuals. In many cases, episodes of abnormal bleeding could, if investigated, have led to earlier diagnosis. Furthermore, the major recent developments in therapy for hemophilia have largely focused on severe disease and, as a group, PWNSH have not been included in many key clinical trials...
May 11, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38733981/evaluating-diagnostic-algorithms-for-heparin-induced-thrombocytopenia-using-two-combined-automated-rapid-immunoassays
#8
JOURNAL ARTICLE
Anna-Lise Bissola, Yi Zhang, Madison Cranstone, Jane C Moore, Theodore E Warkentin, Donald M Arnold, Ishac Nazy
Heparin-induced thrombocytopenia (HIT) is an autoimmune disorder caused by antibodies against platelet factor 4 (PF4) and heparin complexes. Rapid immunoassays (IAs) for detection of these antibodies mark a milestone in HIT diagnosis, despite a higher false-positive rate compared with functional platelet-activation assays. However, combining different rapid IAs may help to improve their diagnostic specificity. Here, we compared the individual performance of the latex immunoturbidimetric assay (LIA; HemosIL HIT-Ab [PF4-H]; sensitivity 91...
May 11, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38733980/recent-advances-in-thrombosis-and-hemostasis-part-x
#9
JOURNAL ARTICLE
Sam Schulman
No abstract text is available yet for this article.
May 11, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38733979/prone-position-and-the-risk-of-venous-thrombosis-in-covid-19-patients-with-respiratory-failure
#10
JOURNAL ARTICLE
Giuseppe Lippi, Camilla Mattiuzzi, Emmanuel J Favaloro
No abstract text is available yet for this article.
May 11, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38733978/the-next-next-generation-of-sequencing-promising-to-boost-research-and-clinical-practice
#11
JOURNAL ARTICLE
Kishore R Kumar, Mark J Cowley, Ryan L Davis
No abstract text is available yet for this article.
May 11, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38733977/heparins-may-not-be-the-optimal-anticoagulants-for-sepsis-and-sepsis-associated-disseminated-intravascular-coagulation
#12
JOURNAL ARTICLE
Toshiaki Iba, Julie Helms, Takaaki Totoki, Jerrold H Levy
Historically, heparin has had the longest historical use as an anticoagulant and continues this day to be the primary therapeutic option for preventing thrombosis and thromboembolism in critically ill hospitalized patients. Heparin is also used to treat sepsis and sepsis-associated disseminated intravascular coagulation (DIC) in various countries. However, the efficacy and safety of heparin for this indication remains controversial, as adequately powered randomized clinical studies have not demonstrated as yet a survival benefit in sepsis and sepsis-associated DIC, despite meta-analyses and propensity analyses reporting improved outcomes without increasing bleeding risk...
May 11, 2024: Seminars in Thrombosis and Hemostasis
https://read.qxmd.com/read/38733668/immune-checkpoint-inhibitor-therapy-in-patients-with-cancer-and-pre-existing-systemic-sclerosis
#13
JOURNAL ARTICLE
Rachel S Wallwork, Jonathan J Kotzin, Laura C Cappelli, Christopher Mecoli, Clifton O Bingham, Fredrick M Wigley, Parker C Wilson, Dana D DiRenzo, Ami A Shah
OBJECTIVE: Immune checkpoint inhibitor (ICI) therapies have dramatically improved outcomes in multiple cancers. ICI's mechanism of action involves immune system activation to augment anti-tumor immunity. Patients with pre-existing autoimmune diseases, such as systemic sclerosis (SSc), were excluded from initial ICI clinical trials due to concern that such immune system activation could precipitate an autoimmune disease flare or new, severe immune related adverse events (irAE). In the present study, we report our experience with ICIs in patients with pre-existing SSc...
May 4, 2024: Seminars in Arthritis and Rheumatism
https://read.qxmd.com/read/38730539/a-year-of-changes-the-end-of-the-pandemic-marks-the-beginning-of-new-priorities
#14
EDITORIAL
Martin Krause, Eric Tzeng, Miklos D Kertai, Benjamin A Abrams
No abstract text is available yet for this article.
June 2024: Seminars in Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/38726260/evaluation-of-public-awareness-knowledge-and-attitudes-about-colorectal-cancer-screening-among-the-general-population-in-al-qunfudah
#15
JOURNAL ARTICLE
Fatimah Aldabali, Batool Alotibi, Ali Alkhaldi, Afnan Alrashdi, Fatimah Alnashri, Ghaday Alqarni, Abdullah Alsllami, Basem Alshareef
Colorectal cancer (CRC) is a malignant tumor of the colon and rectum. It can be cured if detected in the early stage through established screening programs. CRC screening is the best way to improve cancer morbidity and mortality. Various approaches such as stool tests, virtual colonoscopy, and sigmoidoscopy are available for early detection. On average, a person after reaching the age of 45 should begin the screening process for CRC periodically for 5 years. Our study aims to measure the population's awareness and knowledge of the effect of CRC screening on CRC outcomes...
2024: American Journal of Cancer Research
https://read.qxmd.com/read/38724414/mirna-biology-in-chronic-lymphocytic-leukemia
#16
JOURNAL ARTICLE
Recep Bayraktar, Beatrice Fontana, George A Calin, Kinga Nemeth
microRNAs (miRNAs) are a class of small non-coding RNAs that play a crucial regulatory role in fundamental biological processes and have been implicated in various diseases, including cancer. The first evidence of the cancer-related function of miRNAs was discovered in chronic lymphocytic leukemia (CLL) in the early 2000s. Alterations in miRNA expression have since been shown to strongly influence the clinical course, prognosis, and response to treatment in patients with CLL. Therefore, the identification of specific miRNA alterations not only enhances our understanding of the molecular mechanisms underlying CLL but also holds promise for the development of novel diagnostic and therapeutic strategies...
March 19, 2024: Seminars in Hematology
https://read.qxmd.com/read/38724413/corrigendum-to-the-effect-of-psychosocial-support-videos-provided-by-the-community-on-disease-attitudes-and-symptoms-of-pediatric-oncology-patients-randomized-controlled-study-seminars-in-oncology-nursing-40-2024-151570
#17
Remziye Semerci, Eyşan Hanzade Savaş, Ezgi Gizem Gürbüz, Nazlı Başegen, Münevver Erkul, Kübra Alki, Ezgi Paslı Uysalol
No abstract text is available yet for this article.
May 8, 2024: Seminars in Oncology Nursing
https://read.qxmd.com/read/38723409/patient-research-partner-engagement-in-omeract-enhancing-engagement-through-the-implementation-of-patient-engagement-in-research-tools
#18
JOURNAL ARTICLE
Catherine Hofstetter, Shawna Grosskleg, Clayon B Hamilton, Alison M Hoens, Beverley Shea, Peter Tugwell, Dorcas Beaton
OBJECTIVES: This paper describes the evolution and impact of Patient Research Partners (PRPs) in shaping research within OMERACT and provides a framework to enhance their engagement. This session explored one component of a validated framework to evaluate meaningful patient engagement. It provides insights, identifies opportunities for improvement, and recommends using the Patient Engagement in Research (PEIR) Framework, PEIR Plan Guide (workbook), and PEIRS-22 (scale) to guide and measure PRPs' engagement...
April 27, 2024: Seminars in Arthritis and Rheumatism
https://read.qxmd.com/read/38719707/diagnostic-clues-and-pitfalls-in-salivary-gland-fine-needle-aspiration-cytology
#19
REVIEW
Masato Nakaguro
Salivary gland tumors (SGT) display morphological diversity and pose diagnostic challenges. Preoperative fine needle aspiration cytology (FNAC) is a minimally invasive and efficient diagnostic test. However, due to the limited sample size, the final diagnosis may not be established based on FNAC alone. Although cytomorphology and architecture are usually preserved on FNAC, morphologic changes specific to FNAC can complicate the diagnosis. The Milan System for Reporting Salivary Gland Cytopathology categorizes complex FNAC interpretations...
May 3, 2024: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/38719371/postmyocardial-infarction-ventricular%C3%A2-aneurysm-jacc-focus-seminar-5-5
#20
REVIEW
Roberto Lorusso, Matteo Matteucci, Stamatios Lerakis, Daniele Ronco, Lorenzo Menicanti, Samin K Sharma, Pedro R Moreno
Ventricular aneurysm represents a rare complication of transmural acute myocardial infarction, although other cardiac, congenital, or metabolic diseases may also predispose to such condition. Ventricular expansion includes all the cardiac layers, usually with a large segment involved. Adverse events include recurrent angina, reduced ventricular stroke volume with congestive heart failure, mitral regurgitation, thromboembolism, and ventricular arrhythmias. Multimodality imaging is paramount to provide comprehensive assessment, allowing for appropriate therapeutic decision-making...
May 14, 2024: Journal of the American College of Cardiology
keyword
keyword
21759
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.